Announcements Trials
Browse Landscape

Phase

Phase 3 15Phase 2 13Phase 1/2 6Phase 1 4Phase 4 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Hemangioma 1

Interventions

Saline Solution 10Docetaxel 10Bevacizumab 9nilotinib 8enzalutamide 8Paclitaxel 8Letrozole 8Fentanyl 8Everolimus 8Cyclophosphamide 8Carboplatin 8Bupivacaine 8Lidocaine 7Sodium Chloride 6Oxycodone 6Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 6Erlotinib Hydrochloride 6Dexamethasone 6Capecitabine 6Trastuzumab 5Tobacco Use Cessation Devices 5Surveys and Questionnaires 5Nivolumab 5Hydromorphone 5Adalimumab 5fludarabine 4Zoledronic Acid 4Tranexamic Acid 4Tacrolimus 4Rocuronium 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Has results × Prednisolone × Clear all
NCT01995513 2023-09-18

PLATO

Pfizer

Phase 4 Completed
509 enrolled 18 charts
Genitourinary

Prostatic Neoplasms

NCT01908972 2018-12-19

The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma

Seoul National University Hospital

Phase 4 Completed
34 enrolled 18 charts

Hemangioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡